United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $1.47B
| Line Item | Value | % of Total |
|---|---|---|
| Stock Repurchases | $394.5M | 26.9% |
| Other Financing | $52.5M | 3.6% |
| Working Capital | $582.0M | 39.6% |
| Other | $5.3M | 0.4% |
| Net Cash Flow | $434.1M | 29.6% |